To be honest, our team has always sort of rolled our eyes over EoFlow when seeing them at conferences or mentioned over the years. But the JDRF appears to have been ahead of the curve a couple years ago, when the org announced in early 2017 that it would be funding part of EoFlow's research — the first time the T1D group put money behind this particular closed loop company, as well as a first for funding a Korean-based company in diabetes tech.